Le Monde “Le devoir de vigilance « peut devenir un avantage stratégique”

Just in case you missed our webinar, it is now available On-Demand 📺 Find out about the trending ESG topics in the… twitter.com/i/web/status/1…

"Access to medicines and pricing are the top topics related to ESG in the sector," Jordi Lesaffer, V.E's Controvers… twitter.com/i/web/status/1…

"Anti-trust practices are one of the main issues facing the Pharmaceutical & Biotechnology sector," Zineb Raji, Foo… twitter.com/i/web/status/1…

We go live in less than 10 minutes! Will you join us? bit.ly/3ixtuFl

‼️ TODAY ‼️ Join us for a 45-minute FREE webinar covering topics on the Pharmaceutical & Biotechnology Industry, i… twitter.com/i/web/status/1…